Enterococcus faecium W54 (E. faecium W54)

Enterococcus faecium W54 is a specific strain of Gram-positive, lactic acid-producing bacteria primarily utilized as a probiotic component in clinical and dietary supplement applications (Winclove Probiotics, 2023). Unlike the pathogenic strains of E. faecium often associated with hospital-acquired infections, W54 is selected for its ability to strengthen the intestinal epithelial barrier and modulate the host immune system (Koning et al., 2008, PubMed). It is frequently included in multispecies probiotic formulations, such as Ecologic 825, which have been studied for their efficacy in preventing antibiotic-associated diarrhea and managing irritable bowel syndrome (Timmerman et al., 2004, PubMed). The strain functions through competitive exclusion, where it outcompetes potential pathogens for adhesion sites and nutrients within the gut microbiota (NIH, 2022). While W54 itself is considered safe for general use, the species E. faecium is a known reservoir for antibiotic resistance genes, and clinical management of Enterococcal infections often requires potent antibiotics like linezolid or daptomycin (StatPearls, 2023).

Other names

E. faecium W54Enterococcus faecium strain W54

Inhibition of bacterial cell wall synthesis, protein synthesis, or cell membrane integrity by antimicrobial agents.